ID Source | ID |
---|---|
PubMed CID | 9198 |
CHEBI ID | 177498 |
SCHEMBL ID | 1294668 |
MeSH ID | M0143026 |
Synonym |
---|
nsc-89259 |
nsc89259 |
1,2-benzo-9-thiafluorene |
239-35-0 |
naphtho[1,2-b]thianaphthene |
mfcd00010043 |
CHEBI:177498 |
naphtho[1,2-b][1]benzothiole |
benzo[a]dibenzothiophene |
benzo[b]naphtho[2,1-d]thiophene |
1,2-benzodiphenylene sulfide, 99% |
ccris 4012 |
benzo(b)naphtho(2,1-d)thiophene |
nsc 89259 |
naphtho(1,2-b)thianaphthene |
einecs 205-948-0 |
benzo(a)dibenzothiophene |
11-thiabenzo(a)fluorene |
unii-tsv456a44d |
tsv456a44d , |
C20124 |
SCHEMBL1294668 |
FT-0606286 |
benzo(b)naphtho(2,1-d)thiophene [iarc] |
1,2-benzodiphenylene sulfide |
naphtho[1,2-b][1]benzothiophene # |
YEUHHUCOSQOCIX-UHFFFAOYSA-N |
DTXSID8075205 |
1,2-benzo-9-thiafluorene; benzo[a]dibenzothiophene; nsc 89259; naphtho[1,2-b]thianaphthene |
benzo[b]naphtho[2,1-d]thiophene 10 microg/ml in cyclohexane |
J-015283 |
1,2-benzodiphenylene sulphide |
benzo[d]naphtho[1,2-b]thiophene |
Q27290290 |
Excerpt | Relevance | Reference |
---|---|---|
" BaP resulted in a clear dose-response relationship." | ( Evaluation of the carcinogenic potency of 4 environmental polycyclic aromatic compounds following intrapulmonary application in rats. Brune, H; Germann, P; Grimmer, G; Timm, J; Wenzel-Hartung, R; Wosniok, W, 1990) | 0.28 |
Class | Description |
---|---|
organosulfur heterocyclic compound | |
organic heterotricyclic compound | An organic tricyclic compound in which at least one of the rings of the tricyclic skeleton contains one or more heteroatoms. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (17.69) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 6 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |